Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physiological clotting and repair components refer to the integrated system of plasma proteins, enzymes, and cellular elements that maintain vascular integrity and facilitate tissue recovery after injury. This complex network primarily involves the coagulation cascade, where zymogens like prothrombin are converted into active enzymes like thrombin to produce a stable fibrin clot (StatPearls, 2023). Beyond simple hemostasis, these components, particularly platelets, release essential growth factors such as Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor-beta (TGF-beta) that initiate the proliferative phase of wound healing (NCBI, 2015). These factors promote cell migration, extracellular matrix deposition, and angiogenesis, which are critical for restoring tissue function (NIH, 2018). In a therapeutic context, this system is modulated by anticoagulants to prevent pathological thrombosis or by procoagulants and fibrin sealants to manage hemorrhage and accelerate surgical repair (PubChem, 2024). Because the term encompasses a broad range of distinct molecular entities rather than a single receptor or enzyme, it serves as a functional category for describing the biological processes of blood stability and tissue regeneration.
Modulation of the coagulation cascade and growth factor signaling to regulate clot formation and tissue regeneration.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological clotting and repair components.